Epworth Knowledge Services

• Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation J Cardiothorac Vasc Anesth. 2021 Feb;35(2):389-397.

• COVID-19 adenovirus vector vaccine (United States and Canada: Authorized for use): Drug information from UpToDate

• Disseminated intravascular coagulation (DIC) in adults: Evaluation and management from UpToDate (scroll to Clinical Manifestations)

• COVID-19: Hypercoagulability from UpToDate

• Venous thromboembolism (VTE) prophylaxis from National COVID-19 Clinical Evidence Taskforce

• ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns Australian Technical Advisory Group on Immunisation

The term grey literature refers to research that is either unpublished or has been published in non-commercial form. Examples of grey literature include:

Grey literature balances publication bias, reveals prepublication data and emerging theories, and provides a more comprehensive picture.

EKS offers the Grey Literature Gateway where you can search many grey literature websites simultaneously by publication type.

• Australia’s vaccine agreements Australian Dept Health
• COVID‑19 vaccines – are we there yet? Aust Prescr 2021;44:19-25
• COVID-19 vaccine national rollout phases Australian Dept Health
• COVID-19 vaccines Australian Dept Health
• Coronavirus disease 2019 (COVID-19): Vaccines to prevent SARS-CoV-2 infection UpToDate 
• Clinical Resources for Each COVID-19 Vaccine CDC
• Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process WHO